XML 65 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended
Jan. 31, 2014
Jan. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,558,874) $ (8,904,564)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Gain on extinguishment of debt (24,783) 0
Bad debt expense 0 74,393
Depreciation and amortization expense 31,361 20,918
Stock-based compensation expense 2,157,857 2,061,728
Amortization of financing costs 255,396 89,162
Amortization of debt discount 136,751 670,697
Loss on change in fair value of warrant and derivative liabilities 0 5,853,855
Changes in assets and liabilities:    
Accounts receivable 72,916 (548,899)
Due to officers 0 (12,400)
Due from affiliates 4,049 5,504
Prepaid expenses and advances 19,084 (23,666)
Other assets (27,700) 7,020
Accounts payable and accrued liabilities 455,738 764,208
Net cash (used in) provided by operating activities (1,478,205) 57,956
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions, net (250,000) 14,114
Property and equipment acquired (22,931) (45,799)
Net cash (used in) provided by investing activities (272,931) (31,685)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from notes and line of credit payable 2,811,878 594,765
Proceeds from stock option exercise 0 15,750
Payment of note payable (530,000) 0
Distributions to non-controlling interest shareholder (240,000) (400,000)
Proceeds from issuance of common stock 730,000 0
Proceeds from issuance of convertible notes payable 220,000 880,000
Cash payments in connection with convertible note redemption (707,911) 0
Debt issuance costs (258,151) (104,420)
Net cash provided by financing activities 2,025,816 986,095
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS 274,680 1,012,366
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD 1,176,727 164,361
CASH & CASH EQUIVALENTS, END OF PERIOD 1,451,407 1,176,727
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION    
Interest paid 247,465 160,792
Income taxes paid 19,513 9,763
Non-Cash Financing Activities    
Shares issuable and issued for deferred financing costs 45,000 198,935
Warrants issued in connection with convertible note issuance 50,936 387,349
Warrants and derivative reclassified from liabilities to stockholders' deficit 0 6,626,881
Shares Issuable For Services 0 159,334
Notes payable issued in connection with medical clinic acquisitions 299,900 0
Settlement of stock issuable liability with issuance of shares 159,334 0
Shares issued in connection with convertible notes redemption 864,298 0
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption $ 509,890 $ 0